Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00177268 · ClinicalTrials.gov registry record
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
A clinical trial of Atopic Dermatitis and Eczema, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT00177268 is a study of Atopic Dermatitis and Eczema that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 200 participants, below the 608-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00177268, a study of Atopic Dermatitis and Eczema, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.
Conditions Studied
Interventions
- OTHER Blood draw, skin biopsy or urine collection
Study Locations (1)
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2004-10 |
| Est. Completion | 2032-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00177268
The ClinicalTrials.gov registry entry for NCT00177268 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (67% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Atopic Dermatitis appearing as the primary indexed condition, and to 1 intervention - of which Blood draw, skin biopsy or urine collection is the first listed.
NCT00177268 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00177268 about?
NCT00177268 is a clinical study titled "Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research". This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.
What is the current status of trial NCT00177268?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2004-10. Estimated completion is 2032-01.
What conditions does trial NCT00177268 study?
This clinical trial studies the following conditions: Atopic Dermatitis, Eczema, Cutaneous T Cell Lymphoma, Mycosis Fungoides, Sezary Syndrome.
What interventions are being tested in trial NCT00177268?
The interventions under investigation include: Blood draw, skin biopsy or urine collection (OTHER).
Who is sponsoring clinical trial NCT00177268?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00177268 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atopic Dermatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry for Systemic Eczema Treatments
RECRUITING
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
RECRUITING
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
-
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RECRUITING · Phase 2
-
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
RECRUITING · Phase 1
-
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.